Here, the Cholesterol-HDL-Glucose (CHG) index, a composite biomarker that combines cholesterol, HDL-c, and glucose levels proposed as a potential diagnostic tool for metabolic disorders, was associated with an increased risk of stroke in middle-aged and elderly adults without diabetes and HbA1c partially mediated this relationship